THOSE LITTLE OIL FILLED SOFT GELS ARE NOT THE BEST FORM OF VITAMIN D FOR POST BARIATRIC USE. TAKE THE RIGHT VITAMIN D!
Journey Liquid D3 Apple Drops are a game changer for those who’ve had Bariatric Surgery! This product is a small slurp of natural apple flavored water that helps support prevention & management of a D deficiency. A recent study shows 91% of those who have had bariatric surgery are D deficient.
Research shows that natural vitamin D3 cholecalciferol is a better form of vitamin D over synthetic D2 ergocalciferol. Yet, Vitamin D2 is often prescribed by doctors because that is what pharmacies have available. If your doctor prescribes you D2, ask them if you can take vitamin D3 instead. It’s good to be your own advocate.
One dropper of Journey D3 Apple drops contains 10,000 IU of natural Vitamin D3 cholecalciferol in a suspension of purified water flavored with green apple essence and lightly sweetened with stevia.
Eight years after RNY surgery I broke my ankle in a motorcycle accident – the orthopedic surgeon placing the screws found my bones to be ‘like a stick of cold butter’- a severe Vitamin D deficiency was confirmed. OSTEOMALACIA, or ‘soft bones’ is becoming commonplace in bariatric post ops. This product addresses my own struggle with this deficiency. My bariatric-forward primary physician knew that the synthetic D2 prescribed for me would not correct my deficiency. His recommendation: 50,000 IU of Vitamin D3 ONCE A WEEK for 8 weeks. My levels increased from a dismal 8 to 56 (ng/ml). I now take 10,000 IU, once a week to maintain. Happy! ” – Susan Maria Leach
Current evidence suggests regular dosing with D3 cholecalciferol at 50,000 IU at one time, once a week, has advantages over other regimens when replenishing vitamin D stores following deficiency. For long-term supplementation, once levels of 30 – 50ng/ml have been attained, smaller regular doses, such as a single dose of 10,000 IU weekly, may more efficiently maintain these levels. *
In obese patients and/or patients with malabsorption syndromes including bariatric surgery, The Endocrine Society suggests a dose of 10,000 IU/daily of vitamin D to address vitamin D deficiency to maintain a 25(OH)D level above 30 ng/ml, followed by maintenance therapy of 20,000-40,000 IU/weekly. *
Directions: Adults take 1/2 dropper (0.05mL) or 1 dropperful (1 mL) daily or as directed by healthcare professional. Can be added to a beverage or taken from the dropper.
Journey supplements are screened for harmful toxins and do not contain aluminum, lead, mercury, or cadmium. Manufactured in the USA with stringent Good Manufacturing Practices.
Use Journey 3+3 Multi Caps, Tangerine or Berry Tabs as your supplement base. For pre-existing or known deficiencies, add the appropriate Journey component, such as Journey Vitamin D3 Apple Drops, Liquid Calcium Tangelo Shooter, or SuperCal DimaCal® Calcium, Gentle Iron Ferrochel® or as directed by your bariatric healthcare team.
The Case Against Ergocalciferol Vitamin D2 as a Vitamin Supplement*
Supplemental vitamin D is available in 2 distinct forms: ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3)
Pharmacopoeias have officially regarded these 2 forms as equivalent and interchangeable, yet this presumption of equivalence is based on studies of rickets prevention in infants conducted 70 y ago. The emergence of 25-hydroxyvitamin D as a measure of vitamin D status provides an objective, quantitative measure of the biological response to vitamin D administration.
As a result, vitamin D3 has proven to be the more potent form of vitamin D in all primate species, including humans. Despite an emerging body of evidence suggesting several plausible explanations for the greater bioefficacy of vitamin D3, the form of vitamin D used in major preparations of prescriptions in North America is vitamin D2.
The case that vitamin D2 should no longer be considered equivalent to vitamin D3 is based on differences in their efficacy at raising serum 25-hydroxyvitamin D, diminished binding of vitamin D2 metabolites to vitamin D binding protein in plasma, and a nonphysiologic metabolism and shorter shelf life of vitamin D2.
Vitamin D2, or ergocalciferol, should not be regarded as a nutrient suitable for supplementation or fortification.
LISA A HOUGHTON AND REINHOLD VIETH – SCHOOL OF NUTRITION AND DIETETICS, ACADIA UNIVERSITY, WOLFVILLE, CANADA; THE DEPARTMENT OF NUTRITIONAL SCIENCES, UNIVERSITY OF TORONTO, TORONTO, CANADA; AND THE MOUNT SINAI HOSPITAL, TORONTO, CANADA